Research programme: typhoid Vi vaccine - DelSite Biotechnologies
Latest Information Update: 20 Oct 2009
At a glance
- Originator DelSite Biotechnologies
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Typhoid
Most Recent Events
- 16 Jul 2008 qc